An I.M.A.G.E. clone

(#4039129; accession BC055920) containing the cDNA encoding murine PIK3IP1 was obtained from Open Biosystems (Huntsville, AL, USA). The coding sequence was amplified by PCR with Pfu proofreading polymerase, using primers containing BamH1 (forward primer: TCGGATTCGCCACCATGCTGTTGGCTTGGGTACAC) MI-503 in vitro or XbaI (reverse primer: ATTCTAGAAGCTCCAGGGGTGCCAGCCTG) restriction sites. The resulting product was digested with BamHI and XbaI and ligated into the mammalian expression vector pEF1MycHisA (Invitrogen), resulting in the addition of C-terminal Myc and 6His tags to the PIK3IP1 sequence. The amplified sequence was verified by automated sequencing. BioGPS (http://biogps.gnf.org) or the Immunological Staurosporine chemical structure Genome Project (www.immgen.org) was searched using the keyword “pik3ip1.” Results from the former, shown in Fig. 1, represent expression of human PIK3IP1 message across a wide range of tissues and cell types, while data from the latter (not shown) confirmed expression of murine PIK3IP1 in T cells.

Jurkat and D10 T cells were transfected by electroporation. Cells in 400 μl total volume were pulsed at 250V (D10) or 260V (Jurkat), 950 μF, with exponential decay. For ectopic expression, cells were transfected with 15-μg luciferase reporter and the indicated concentrations of expression plasmids. Eighteen hours after transfection, cells were either lysed for western blot analysis or stimulated for 6 h, followed by determination of luciferase activity. For siRNA knock-down, cells were transfected with 15 μg of luciferase reporter and the indicated amounts of siRNA. Forty-two hours after transfection,

cells were stimulated for either 15 min (for phospho-Akt analysis) or for 6 h (for luciferase), as indicated. Microplate luciferase assays and western blotting were performed as described previously [15]. Jurkat Urocanase T cells were transfected with siRNA specific for PIK3IP1. After 48 h, cells were stimulated for 24 h with anti-TCR/CD28 antibodies. Cell-free supernatants were analyzed by ELISA for human IL-2, using OptEIA matched antibodies (BD Bioscience, San Diego, CA, USA). We thank S. Gaffen and members of the Kane lab for helpful discussions and for critical reading of the manuscript. This work was supported by NIH grants GM080398 (to L.P.K.) and CA105242 (to M.C.D.). The authors declare no financial or commercial conflict of interest. Disclaimer: Supplementary materials have been peer-reviewed but not copyedited. Supporting Information Figure 1: Duplicate experiment showing increased Akt S473 phosphorylation after PIK3IP1 knock-down. Control and knock-down panels are from the same western blot, with the same exposure. See Fig. 3 of the main text for more detail. Supporting Information Figure 2: Effects of PIK3IP1 knockdown on cytokine message and protein in a mouse T cell line.